enVVeno Medical Corporation
NASDAQ Capital MarketTotal Valuation
enVVeno Medical Corporation carries a market capitalization of 188,783.00, placing it among publicly traded companies globally. Its enterprise value stands at -13.96M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 188,783.00 |
| Enterprise Value | -13.96M |
Share Statistics
enVVeno Medical Corporation currently has 655,521.00 shares outstanding.
| Shares Outstanding | 655,521.00 |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | 0.34 |
| P/TBV Ratio | 0.34 |
| P/FCF Ratio | -0.46 |
| P/OCF Ratio | -0.46 |
Financial Position
enVVeno Medical Corporation maintains a current ratio of 11.70, meaning it holds 11.7x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 11.70 |
| Quick Ratio | 11.39 |
| Debt / Equity | 2.44 |
| Debt / EBITDA | -0.03 |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | -58.53 |
| Return on Assets (ROA) | -53.09 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
enVVeno Medical Corporation's stock has declined approximately -57.55362% over the past 52 weeks. The 50-day moving average sits at 10.82, while the 200-day moving average is 11.03.
| Beta (5Y) | N/A |
| 52-Week Price Change | -57.55362% |
| 50-Day Moving Average | 10.82 |
| 200-Day Moving Average | 11.03 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -16.36M, while operating income came in at -16.75M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -16.75M |
| Pretax Income | -15.72M |
| Net Income | -15.72M |
| EBITDA | -16.36M |
| EBIT | -16.75M |
| Earnings Per Share (EPS) | -24.82 |
Balance Sheet
enVVeno Medical Corporation holds 21.49M in cash and equivalents against 505,000.00 in total debt, resulting in a net debt position of -2.84M. Total book value stands at 20.67M, with working capital of 20.20M providing operational flexibility.
| Cash & Cash Equivalents | 21.49M |
| Total Debt | 505,000.00 |
| Net Debt | -2.84M |
| Equity (Book Value) | 20.67M |
| Book Value Per Share | 31.53 |
| Working Capital | 20.20M |
Cash Flow
enVVeno Medical Corporation produced -14.62M in operating cash flow over the past twelve months.
| Operating Cash Flow | -14.62M |
| Capital Expenditures | N/A |
| Free Cash Flow | -14.62M |
| FCF Per Share | -23.08 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -14.57 |
| FCF Yield | -215.47 |
Stock Splits
enVVeno Medical Corporation's most recent stock split took place on January 20, 2026 with a 35:1 split ratio.
| Last Split Date | 1/20/2026 |
| Split Ratio | 35:1 |
Scores
enVVeno Medical Corporation posts an Altman Z-Score of -10.30, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -10.30 |